House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Obstetrics & gynaecology

Intrapartum care

NICE · 2026 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

NICE NG235 addresses care during labour and birth, including informed choice, analgesia, term rupture of membranes, maternal monitoring, third-stage care and initial haemorrhage management. This selected summary includes the 2025 fluid-balance and water-birth recommendations within the current captured guidance. Care setting and escalation depend on ongoing maternal and fetal assessment.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Support informed choices and safe transfer

  • Discuss birth preferences early, record choices and revisit them when circumstances change. Women can change their minds, including during labour. [1]
  • Explain benefits and risks, allow questions and thinking time where possible, and obtain consent before an intervention. Support one-to-one care and do not leave someone in established labour alone except briefly or at her request. [1]
  • Encourage comfortable movement and positions other than lying flat on the back, and support the chosen birth companion. [1]
  • Base transfer on clinical findings and discuss reasons, expected timing and concerns with the woman. Obtain informed consent and arrange transfer as soon as possible after the decision. [1]

Offer pain relief with the required safety measures

  • Breathing exercises, a shower or bath and massage may reduce latent-phase pain. Offer labouring in water; check maternal and water temperature hourly, keeping the water at or below 37.5°C. [1]
  • Explain that systemic opioids offer limited relief and can cause maternal sedation, nausea and neonatal respiratory depression or drowsiness. Give an antiemetic with intravenous or intramuscular opioids; avoid entering water within 2 hours or while drowsy. [1]
  • Use remifentanil patient-controlled analgesia only in an obstetric unit. Require continuous trained one-to-one midwifery presence, continuous breathing and pulse-oximetry monitoring, immediately available oxygen and anaesthetic support, and a respiratory-depression response protocol. Use continuous cardiotocography when other risk factors are present. [1]
  • Discuss regional analgesia when requested and support an informed choice. Secure intravenous access before starting; routine fluid preloading is unnecessary for low-dose epidural or combined spinal–epidural analgesia. [1]

Assess rupture of membranes at term

  • After suspected rupture at term, assess risks promptly. If rupture is uncertain, offer a speculum examination; avoid digital vaginal examination when contractions are absent. Do not perform a speculum examination if rupture is certain. [1]
  • For prelabour rupture of membranes at term (at or after 37+0 weeks), offer a choice between expectant management for up to 24 hours and induction as soon as possible. If expectant management is chosen and labour has not begun after approximately 24 hours, offer induction. [1]
  • After prelabour rupture of membranes at term, while awaiting induction or continuing expectant management, advise temperature recording every 4 hours while awake and immediate reporting of changed vaginal-loss colour or smell. Assess fetal movement and heart rate initially and every 24 hours before labour; reduced movements require immediate reporting. [1]
  • For term rupture with a positive group B streptococcus test during the current pregnancy, or a previous baby affected by GBS infection, offer immediate induction, or caesarean birth if already planned. Follow separate neonatal-infection guidance for intrapartum antibiotics. [1]

Monitor progress, fluid balance and emerging risk

  • In the first stage, document contraction frequency half-hourly, pulse hourly, and temperature, blood pressure and respiratory rate every 4 hours. Offer a 4-hourly vaginal examination, or one in response to the woman’s wishes if there is concern about progress, after abdominal palpation and assessment of vaginal loss. [1]
  • Encourage drinking to thirst rather than excess. Track fluid balance when there are intake or output concerns, intravenous fluids or an oxytocin infusion, because excessive fluid can cause dangerous maternal and neonatal hyponatraemia. [1]
  • With positive fluid balance of at least 1500 mL or clinical concern, request obstetric review, check sodium and arrange obstetric-setting transfer where necessary. With confirmed hyponatraemia, inform the senior obstetric, anaesthetic, neonatal and delivery-suite teams as soon as possible; notify them immediately if symptoms occur or sodium is below 125 mmol/L. [1]
  • Document meconium and undertake a full risk assessment. Discuss obstetric-led care, possible continuous fetal monitoring and the potential need for advanced neonatal life support at birth. [1]

Protect the perineum and manage the third stage

  • Offer a comfortable warm wet perineal compress once the presenting part distends the perineum, continuing until birth. Consider water-soluble perineal massage if preferred; these recommendations exclude water birth. Do not perform routine episiotomy during spontaneous vaginal birth. [1]
  • Consider water birth after discussing potential reductions in postpartum haemorrhage, neonatal admission and severe tears in multiparous women, but increased cord-snapping risk. Evidence is inconclusive about differences in perinatal death. [1]
  • During active third-stage management, do not clamp before 1 minute after birth unless cord integrity is concerning or the baby’s heart rate is below 60 and not rising. Clamp before 5 minutes after birth for controlled traction, but support a request for later clamping; traction requires oxytocin and signs of placental separation. [1]
  • Diagnose prolonged third stage after 30 minutes with active management or 60 minutes with physiological management. Retained placenta needs intravenous access and appropriate obstetric care; never undertake uterine exploration or manual removal without anaesthesia. [1]

Respond promptly to haemorrhage and postpartum concerns

  • For postpartum haemorrhage, call for help and initiate bladder emptying, uterine massage, uterotonics, intravenous fluids and controlled cord traction if the placenta remains undelivered. Continuously assess bleeding and maternal condition, identify the source and arrange obstetric-led care. [1]
  • In addition to uterotonics, give tranexamic acid 1 g intravenously over 10 minutes for postpartum haemorrhage. Repeat if necessary after at least 30 minutes for continuing bleeding. [1]
  • If postpartum haemorrhage persists, consider near-patient coagulation testing and blood products, examine under anaesthesia, ensure the uterus is empty and repair trauma. Consider balloon tamponade before surgical options. [1]
  • After regional analgesia or anaesthesia, check for the ability to perform a straight leg raise by 4 hours after the last dose. If this has not returned, obtain urgent obstetric-anaesthetic review. [1]

Limitations and use

  • This is a selected pathway summary, not the full birth-setting eligibility tables, first- or second-stage delay algorithm, fetal-monitoring protocol or neonatal-resuscitation protocol.
  • Detailed epidural and remifentanil dosing, uterotonic selection and contraindication tables, operative-birth procedures and perineal-repair techniques require the complete guideline and local protocols.
  • UK service arrangements and medicine availability need local adaptation. The summary does not replace assessment for obstetric emergencies or the linked neonatal-infection guidance.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Intrapartum care

    Selected recommendation material consulted

Original guideline

Publication details

Issuing organisation
NICE
First published
29 September 2023
Publisher’s latest update
9 June 2026
Resource type
Clinical guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Support informed choices and safe transfer
  • Offer pain relief with the required safety measures
  • Assess rupture of membranes at term
  • Monitor progress, fluid balance and emerging risk
  • Protect the perineum and manage the third stage
  • Respond promptly to haemorrhage and postpartum concerns
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House